Advancements in Care Through Precision Oncology

No two breast cancers are exactly alike, and treatment is becoming more personalized than ever before. Join us as we explore how precision oncology is changing the way breast cancer is diagnosed and treated, including the latest advances in genetic testing, biomarkers, and targeted therapies, and what these developments may mean for you.

Join us for this educational webinar as our expert speaker discusses:

• What precision oncology is and why it matters
• Advances in genomic and molecular testing
• Emerging targeted therapies and personalized treatment approaches
• Advances in molecular and biomarker testing
• Recent clinical trial findings and emerging research
• Access to precision medicine for people with breast cancer

Bring your questions or submit them in advance to Rebecca Armstrong at rarmstrong@cbcn.ca and learn about the resources, supports and strategies that can help you make informed decisions.

More about our Expert Speaker

Katherina Baranova is a graduate of Schulich School of Medicine for medical school followed by Diagnostic and Molecular Pathology residency. She is currently in the second year of the European Masters of Molecular Pathology program, and a practicing locum pathologist with experience in breast pathology at Cambridge Memorial Hospital, Ontario. Dr. Baranova is a published scientific author on topics related to breast cancer chemotherapy resistance, molecular signatures in rare central nervous system tumours, and genetic syndromes in renal tumours.

This webinar has been made possible through unrestricted educational grants from Novartis Canada at the Gold level; Pfizer and AstraZeneca at the Silver level; and Roche at the Bronze level.

Our Stories

More Stories

Tell Us your Story